Sign In
Get Clay Free →

Suggestions

    Geoffrey Laff

    Experienced Biotech/Healthcare Professional

    Geoffrey Laff is a versatile executive with a focus on drug development and translational medicine, specializing in oncology, immunology, and rare genetic disorders.

    His career includes diverse roles in venture capital investing, buy-side equity analysis, corporate strategy, competitive intelligence, preclinical portfolio management, search and evaluation, technology scouting, licensing, partnering, and M&A.

    Geoffrey Laff's educational background is extensive, including studies in Orchestral Performance at Interlochen Center for the Arts, Postdoctoral Fellow in Oncology at Harvard Medical School, Ph.D. in Molecular Cell Biology from Yale University, and a B.S. in Biology also from Yale University.

    He has been associated with various prestigious organizations such as the University of Minnesota Venture Center as a member of the Business Advisory Group, Spotlight Innovation Inc. as the Senior Vice President of Business Development, and Synapse Medical Communications as the Senior Director of Oncology, Medical, and Scientific Affairs.

    Geoffrey Laff has also held positions like Biotechnology and Healthcare Strategist, Medical Communications Expert, Vice President and Director of Biotechnology Analysis, Partner in Oncology, and Senior Venture Associate in different organizations related to healthcare and biotechnology.

    Highlights

    Potential Zika Virus Therapies Identified by Researchers - The Wall Street Journal
    Potential Zika Virus Therapies Identified by Researchers - The Wall Street Journal
    Potential Zika Virus Therapies Identified by Researchers - The Wall Street Journal
    Potential Zika Virus Therapies Identified by Researchers - The Wall Street Journal

    Related Questions

    What are Geoffrey Laff's main responsibilities at the University of Minnesota Venture Center?
    How has Geoffrey Laff contributed to drug development in oncology and immunology?
    What companies has Geoffrey Laff worked for in the biotech industry?
    Can you provide examples of Geoffrey Laff's work in translational medicine?
    What is Geoffrey Laff's educational background?